Phase 4
N=30
Tobacco Cessation Treatment Preferences Among Veteran Smokers
Tobacco Use
Bottom Line
View on ClinicalTrials.gov: NCT05277207 ↗Enrolled (actual)
30
Serious AEs
0.0%
Results posted
May 2024
Primary outcome: Primary: Number of Participants Who Report Post-treatment Satisfaction — 15; 10 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Personalized Smoking Cessation Facilitation Meetings (Behavioral); Personalized Smoking Cessation Pharmacotherapy (Drug); Personalized Text Messaging Support (Behavioral); SmokefreeVET (Behavioral); VA Quitline (Behavioral); Education about pharmacotherapy (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Sep 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Report Post-treatment Satisfaction |
15; 10 | — |
| SECONDARY Treatment Attendance |
15; 3 | — |
| SECONDARY Therapist-rated Treatment Acceptability in Active Treatment Group |
14 | — |
| SECONDARY Proportion of Participants Who Completed Treatment in the Active Treatment Group |
100 | — |
Summary
There are significant barriers to tobacco cessation treatment for patients and providers in specialty care clinical settings. Specialty providers cite several barriers to delivering evidence-based tobacco cessation care, including insufficient time and lack of training. In addition, a large proportion of patients who begin tobacco cessation treatment do not quit. Use of healthcare technology (i.e., telehealth, electronic health record, and computerized treatment algorithms based on patient data) to improve patients' ability to quit tobacco use. The purpose of this study is to demonstrate the feasibility of a larger trial, and to evaluate the acceptability of the intervention design. Thirty participants will be assigned to receive either 1) a treatment that includes personalized counseling, tobacco cessation medications, and text messaging; or 2) referral to Department of Veterans Affairs' Quitline program plus SmokefreeVET, a text messaging program.
Eligibility Criteria
Inclusion Criteria
- Durham VA patient
- willing to complete study procedures
- appointment in Durham VA Infectious Disease (ID) Clinic or Durham VA Cardiology Section within the past 12 months
- currently smoking 7 times per week (cigarettes, cigars, cigarillos, hookah, etc.) and/or using 1 can of smokeless tobacco per week
Exclusion Criteria
- participation in Aim 3 (already received the intervention)
- current hospitalization (recent hospitalization is acceptable)
- currently not using combustible or smokeless tobacco (vaping only)
- acute risk for suicide documented in the medical record
- or inability to complete study procedures
Data sourced from ClinicalTrials.gov (NCT05277207). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.